TaskUs to Participate in the Morgan Stanley Technology,
NEW BRAUNFELS, Texas, March 03, 2023 (GLOBE NEWSWIRE) -- TaskUs, Inc. (Nasdaq: TASK), a leading provider of outsourced digital services and......
Daseke Announces Chief Operating Officer Transition
Specialized Segment leader and transportation industry veteran, Scott Hoppe, to become EVP and COO effective June 1, 2023......
Cidara Therapeutics Announces Pricing of Public Offerings
SAN DIEGO, March 03, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics......
Morphic to Present at TD Cowen 43rd Annual Health Care
WALTHAM, Mass., March 03, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing a new generation of oral......
Consolidated Water to Meet with Investors at the 35th
GEORGE TOWN, Cayman Islands, March 03, 2023 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading developer and......
TG Therapeutics Announces Data Presentations from the
NEW YORK, March 03, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the schedule of data presentations highlighting data......
The Shyft Group to Present at the Raymond James 44th Annual
NOVI, Mich., March 03, 2023 (GLOBE NEWSWIRE) -- The Shyft Group, Inc. (NASDAQ: SHYF) (“Shyft” or the “Company”), the North American leader in specialty......
Societal CDMO to Participate at 35th Annual Roth
SAN DIEGO and GAINESVILLE, Ga., March 03, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract......
Eagle Pharmaceuticals to Host Fourth Quarter and Full Year
WOODCLIFF LAKE, N.J., March 03, 2023 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the......
ProKidney to Participate in TD Cowen’s 43rd Annual Health
WINSTON-SALEM, N.C., March 03, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) (“ProKidney”), a leading late clinical-stage cellular therapeutics......